Hypertension Drugs Tied To Higher Cancer Risk
The study, published online in The Lancet Oncology journal, looked at angiotensin-receptor blockers, a widely used drug class used to treat hypertension, heart failure, diabetic nephropathy, and to reduce cardiovascular risk.
To assess whether ARBs are linked to cancer, researchers from Case Western Reserve University in Cleveland looked through clinical trials published before November that included any...
Already a subscriber? Click here to login